The incidence of G-CSF administration for leukopenia in the acute onset group was 8.2 per 1000 person-years (0.1% during the 62 days), and that in the late onset group was 0.9 per 1000 person-years (Fig. 2F). This evidence concerns the gene CSF3 and Decreased total leukocyte count.